KEGG   PATHWAY: uah04650
Entry
uah04650                    Pathway                                
Name
Natural killer cell mediated cytotoxicity - Ursus arctos horribilis (North American brown bear)
Description
Natural killer (NK) cells are lymphocytes of the innate immune system that are involved in early defenses against both allogeneic (nonself) cells and autologous cells undergoing various forms of stress, such as infection with viruses, bacteria, or parasites or malignant transformation. Although NK cells do not express classical antigen receptors of the immunoglobulin gene family, such as the antibodies produced by B cells or the T cell receptor expressed by T cells, they are equipped with various receptors whose engagement allows them to discriminate between target and nontarget cells. Activating receptors bind ligands on the target cell surface and trigger NK cell activation and target cell lysis. However Inhibitory receptors recognize MHC class I molecules (HLA) and inhibit killing by NK cells by overruling the actions of the activating receptors. This inhibitory signal is lost when the target cells do not express MHC class I and perhaps also in cells infected with virus, which might inhibit MHC class I exprssion or alter its conformation. The mechanism of NK cell killing is the same as that used by the cytotoxic T cells generated in an adaptive immune response; cytotoxic granules are released onto the surface of the bound target cell, and the effector proteins they contain penetrate the cell membrane and induce programmed cell death.
Class
Organismal Systems; Immune system
Pathway map
uah04650  Natural killer cell mediated cytotoxicity
uah04650

Other DBs
GO: 0042267
Organism
Ursus arctos horribilis (North American brown bear) [GN:uah]
Gene
113247403  LOW QUALITY PROTEIN: killer cell immunoglobulin-like receptor 3DL3 [KO:K07980]
113257892  NKG2-A/NKG2-B type II integral membrane protein-like isoform X1 [KO:K06541]
113257894  NKG2-A/NKG2-B type II integral membrane protein-like [KO:K06541]
113258081  NKG2-A/NKG2-B type II integral membrane protein-like [KO:K06541]
113257891  NKG2-F type II integral membrane protein-like [KO:K06541]
113257897  KLRD1; natural killer cells antigen CD94 isoform X1 [KO:K06516]
113257950  PTPN6; tyrosine-protein phosphatase non-receptor type 6 [KO:K05697] [EC:3.1.3.48]
113266983  PTPN11; tyrosine-protein phosphatase non-receptor type 11 isoform X1 [KO:K07293] [EC:3.1.3.48]
113270688  tyrosine-protein phosphatase non-receptor type 11-like [KO:K07293] [EC:3.1.3.48]
113242979  ICAM1; intercellular adhesion molecule 1 [KO:K06490]
113265276  ICAM2; intercellular adhesion molecule 2 isoform X1 [KO:K06523]
113267681  ITGAL; integrin alpha-L isoform X1 [KO:K05718]
113250821  ITGB2; integrin beta-2 [KO:K06464]
113269957  PTK2B; protein-tyrosine kinase 2-beta isoform X1 [KO:K05871] [EC:2.7.10.2]
113266577  VAV2; guanine nucleotide exchange factor VAV2 isoform X1 [KO:K05730]
113244955  VAV3; guanine nucleotide exchange factor VAV3 [KO:K05730]
113242671  VAV1; proto-oncogene vav [KO:K05730]
113267943  RAC1; ras-related C3 botulinum toxin substrate 1 [KO:K04392]
113241811  RAC2; ras-related C3 botulinum toxin substrate 2 isoform X1 [KO:K07860]
113244670  RAC3; ras-related C3 botulinum toxin substrate 3 [KO:K07861]
113269353  PAK1; serine/threonine-protein kinase PAK 1 [KO:K04409] [EC:2.7.11.1]
113240885  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 isoform X1 [KO:K04368] [EC:2.7.12.2]
113242822  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
113267646  MAPK3; mitogen-activated protein kinase 3 isoform X1 [KO:K04371] [EC:2.7.11.24]
113247020  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
113243711  TNF; tumor necrosis factor [KO:K03156]
113261702  CSF2; granulocyte-macrophage colony-stimulating factor isoform X1 [KO:K05427]
113256304  IFNG; interferon gamma [KO:K04687]
113261030  natural cytotoxicity triggering receptor 2-like [KO:K06742]
113261043  NCR2; natural cytotoxicity triggering receptor 2 [KO:K06742]
113244840  TYROBP; TYRO protein tyrosine kinase-binding protein isoform X1 [KO:K07992]
113268359  LCK; tyrosine-protein kinase Lck [KO:K05856] [EC:2.7.10.2]
113267145  uncharacterized protein LOC113267145 [KO:K06856]
113268656  low affinity immunoglobulin gamma Fc region receptor III-B-like isoform X1 [KO:K06463]
113247364  leukocyte immunoglobulin-like receptor subfamily B member 3A [KO:K06741]
113243714  NCR3; natural cytotoxicity triggering receptor 3 [KO:K06743]
113246719  FCER1G; high affinity immunoglobulin epsilon receptor subunit gamma [KO:K07983]
113262884  CD247; T-cell surface glycoprotein CD3 zeta chain isoform X1 [KO:K06453]
113246717  tyrosine-protein kinase ZAP-70 [KO:K07360] [EC:2.7.10.2]
113270132  SYK; tyrosine-protein kinase SYK [KO:K05855] [EC:2.7.10.2]
113264079  LCP2; lymphocyte cytosolic protein 2 [KO:K07361]
113267622  LAT; LOW QUALITY PROTEIN: linker for activation of T-cells family member 1 [KO:K07362]
113267780  LAT2; linker for activation of T-cells family member 2 isoform X1 [KO:K26356]
113258609  PLCG1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1 [KO:K01116] [EC:3.1.4.11]
113252535  PLCG2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 [KO:K05859] [EC:3.1.4.11]
113245745  SH3BP2; SH3 domain-binding protein 2 isoform X1 [KO:K07984]
113254799  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
113270537  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
113253989  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
113256705  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
113254730  PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649]
113255266  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
113264721  FYN; tyrosine-protein kinase Fyn isoform X1 [KO:K05703] [EC:2.7.10.2]
113245295  SHC1; SHC-transforming protein 1 isoform X1 [KO:K06279]
113242690  SHC2; SHC-transforming protein 2 isoform X1 [KO:K17447]
113270120  SHC3; SHC-transforming protein 3 isoform X1 [KO:K17448]
113269597  SHC4; SHC-transforming protein 4 [KO:K17449]
113244637  GRB2; growth factor receptor-bound protein 2 [KO:K04364]
113266205  SOS2; son of sevenless homolog 2 isoform X1 [KO:K03099]
113241630  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
113257418  GTPase HRas-like [KO:K02833]
113257792  KRAS; GTPase KRas isoform X1 [KO:K07827]
113244394  NRAS; GTPase NRas [KO:K07828]
113265980  ARAF; serine/threonine-protein kinase A-Raf [KO:K08845] [EC:2.7.11.1]
113265167  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
113257190  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
113259554  UL16-binding protein 1-like [KO:K07986]
113259553  UL16-binding protein 1-like isoform X1 [KO:K07986]
113257895  NKG2-D type II integral membrane protein-like isoform X1 [KO:K06728]
113244836  HCST; hematopoietic cell signal transducer isoform X1 [KO:K07988]
113246744  CD48; CD48 antigen [KO:K06479]
113246635  CD244; natural killer cell receptor 2B4 [KO:K06582]
113270001  PPP3CC; serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
113259177  PPP3CB; serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
113263105  PPP3CA; serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
113244743  PPP3R1; calcineurin subunit B type 1 [KO:K06268]
113260378  PPP3R2; calcineurin subunit B type 2 [KO:K06268]
113253544  NFATC1; nuclear factor of activated T-cells, cytoplasmic 1 isoform X1 [KO:K04446]
113258729  NFATC2; nuclear factor of activated T-cells, cytoplasmic 2 isoform X1 [KO:K17332]
113265250  PRKCA; protein kinase C alpha type [KO:K02677] [EC:2.7.11.13]
113267584  PRKCB; protein kinase C beta type isoform X1 [KO:K19662] [EC:2.7.11.13]
113247385  PRKCG; protein kinase C gamma type [KO:K19663] [EC:2.7.11.13]
113268669  SH2D1B; SH2 domain-containing protein 1B [KO:K07989]
113270933  SH2D1A; SH2 domain-containing protein 1A [KO:K07990]
113259485  IFNGR1; interferon gamma receptor 1 [KO:K05132]
113264675  IFNGR2; interferon gamma receptor 2 [KO:K05133]
113260290  interferon alpha-1/2-like [KO:K05414]
113260291  interferon alpha-1/2-like [KO:K05414]
113260293  interferon alpha-1/2-like [KO:K05414]
113260294  interferon alpha-2-like [KO:K05414]
113260295  IFNB1; interferon beta [KO:K05415]
113264796  IFNAR1; interferon alpha/beta receptor 1 [KO:K05130]
113255024  TNFSF10; tumor necrosis factor ligand superfamily member 10 isoform X1 [KO:K04721]
113262825  FASLG; tumor necrosis factor ligand superfamily member 6 [KO:K04389]
113258968  FAS; tumor necrosis factor receptor superfamily member 6 [KO:K04390]
113245994  granzyme B-like isoform X1 [KO:K01353] [EC:3.4.21.79]
113259145  PRF1; perforin-1 [KO:K07818]
113262259  CASP3; caspase-3 isoform X1 [KO:K02187] [EC:3.4.22.56]
113258065  BID; BH3-interacting domain death agonist isoform X1 [KO:K04726]
Compound
C00076  Calcium cation
C00165  Diacylglycerol
C01245  D-myo-Inositol 1,4,5-trisphosphate
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Chiesa S, Tomasello E, Vivier E, Vely F.
  Title
Coordination of activating and inhibitory signals in natural killer cells.
  Journal
Mol Immunol 42:477-84 (2005)
DOI:10.1016/j.molimm.2004.07.030
Reference
  Authors
Maghazachi AA.
  Title
Insights into seven and single transmembrane-spanning domain receptors and their signaling pathways in human natural killer cells.
  Journal
Pharmacol Rev 57:339-57 (2005)
DOI:10.1124/pr.57.3.5
Reference
  Authors
Vivier E, Nunes JA, Vely F.
  Title
Natural killer cell signaling pathways.
  Journal
Science 306:1517-9 (2004)
DOI:10.1126/science.1103478
Reference
  Authors
Colucci F, Di Santo JP, Leibson PJ.
  Title
Natural killer cell activation in mice and men: different triggers for similar weapons?
  Journal
Nat Immunol 3:807-13 (2002)
DOI:10.1038/ni0902-807
Reference
  Authors
Perussia B.
  Title
Signaling for cytotoxicity.
  Journal
Nat Immunol 1:372-4 (2000)
DOI:10.1038/80808
Reference
  Authors
Smyth MJ, Cretney E, Kelly JM, Westwood JA, Street SE, Yagita H, Takeda K, van Dommelen SL, Degli-Esposti MA, Hayakawa Y.
  Title
Activation of NK cell cytotoxicity.
  Journal
Mol Immunol 42:501-10 (2005)
DOI:10.1016/j.molimm.2004.07.034
Reference
  Authors
Djeu JY, Jiang K, Wei S.
  Title
A view to a kill: signals triggering cytotoxicity.
  Journal
Clin Cancer Res 8:636-40 (2002)
Reference
  Authors
Smyth MJ, Takeda K, Hayakawa Y, Peschon JJ, van den Brink MR, Yagita H.
  Title
Nature's TRAIL--on a path to cancer immunotherapy.
  Journal
Immunity 18:1-6 (2003)
DOI:10.1016/S1074-7613(02)00502-2
Reference
  Authors
Colonna M.
  Title
Fine-tuning NK cell responses: it's a family affair.
  Journal
Nat Immunol 6:961-2 (2005)
DOI:10.1038/ni1005-961
Reference
PMID:8942070
  Authors
Bonnema JD, Leibson PJ.
  Title
Signal transduction during NK cell activation.
  Journal
Chem Immunol 64:28-43 (1996)
Reference
  Authors
Tassi I, Presti R, Kim S, Yokoyama WM, Gilfillan S, Colonna M.
  Title
Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors.
  Journal
J Immunol 175:749-54 (2005)
DOI:10.4049/jimmunol.175.2.749
Reference
PMID:9143705
  Authors
Rao A, Luo C, Hogan PG.
  Title
Transcription factors of the NFAT family: regulation and function.
  Journal
Annu Rev Immunol 15:707-47 (1997)
DOI:10.1146/annurev.immunol.15.1.707
Reference
  Authors
Wu J, Lanier LL.
  Title
Natural killer cells and cancer.
  Journal
Adv Cancer Res 90:127-56 (2003)
DOI:10.1016/S0065-230X(03)90004-2
Reference
  Authors
Cerwenka A, Lanier LL.
  Title
Natural killer cells, viruses and cancer.
  Journal
Nat Rev Immunol 1:41-9 (2001)
DOI:10.1038/35095564
Reference
  Authors
Blott EJ, Griffiths GM.
  Title
Secretory lysosomes.
  Journal
Nat Rev Mol Cell Biol 3:122-31 (2002)
DOI:10.1038/nrm732
Reference
  Authors
Lieberman J.
  Title
The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal.
  Journal
Nat Rev Immunol 3:361-70 (2003)
DOI:10.1038/nri1083
Reference
  Authors
Lord SJ, Rajotte RV, Korbutt GS, Bleackley RC.
  Title
Granzyme B: a natural born killer.
  Journal
Immunol Rev 193:31-8 (2003)
DOI:10.1034/j.1600-065X.2003.00044.x
Reference
  Authors
Liu D, Xu L, Yang F, Li D, Gong F, Xu T.
  Title
Rapid biogenesis and sensitization of secretory lysosomes in NK cells mediated by target-cell recognition.
  Journal
Proc Natl Acad Sci U S A 102:123-7 (2005)
DOI:10.1073/pnas.0405737102
Reference
PMID:9862693
  Authors
Trotta R, Puorro KA, Paroli M, Azzoni L, Abebe B, Eisenlohr LC, Perussia B.
  Title
Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-regulated kinases.
  Journal
J Immunol 161:6648-56 (1998)
Reference
  Authors
Jevremovic D, Billadeau DD, Schoon RA, Dick CJ, Leibson PJ.
  Title
Regulation of NK cell-mediated cytotoxicity by the adaptor protein 3BP2.
  Journal
J Immunol 166:7219-28 (2001)
DOI:10.4049/jimmunol.166.12.7219
Related
pathway
uah04010  MAPK signaling pathway
uah04020  Calcium signaling pathway
uah04060  Cytokine-cytokine receptor interaction
uah04210  Apoptosis
uah04630  JAK-STAT signaling pathway
KO pathway
ko04650   
LinkDB

DBGET integrated database retrieval system